PHM 554 ACTUAL EXAM 2 |85 COMPLETE AND GRADED QUESTIONS
AND ANSWERS 2026 LATEST UPDATED | 100% GRADED CORRECT |
100% GUARANTEED TO PASS | GET A+
What are the pre-clinical candidate development criteria for new drugs? - (answer)Proof of
efficacy (in vitro potency, in vitro selectivity, efficacy in animals, target engagement, disease
markers) and proof of safety (ancillary pharmacology, metabolism data, off-target in vitro
activities, dose limiting toxicity studies).
What occurs during the Discovery Process: Preclinical Testing? - (answer)Initial
pharmacokinetic tests (absorption, distribution, metabolism, excretion, and toxicity), alteration of
molecule structure for safety/effectiveness, animal testing for safety confirmation, patent pursuit,
and filing of Investigational New Drug (IND) application.
When should the Investigational New Drug (IND) application be filed? - (answer)Before clinical
testing.
When should the New Drug Application (NDA) be submitted? - (answer)At the end of Phase 3,
depending on results.
, What are the key features of Phase 1 clinical trials? - (answer)Focus on safety with 20-80 healthy
volunteers, assessment of most frequent adverse effects, and metabolism & excretion.
What are the key features of Phase 2 clinical trials? - (answer)Focus on effectiveness with
hundreds of patients with disease, may include dose determination, continued safety evaluation,
and discussions on Phase 3 methodologies.
What are the key features of Phase 3 clinical trials? - (answer)Focus on safety and effectiveness
with thousands of patients, may address sub-populations and relevant comparators, and involves
submission of NDA or Biologics License Application (BLA).
What are the US criteria for drug approval? - (answer)Safety, efficacy, and good manufacturing
practices.
What is the purpose of Phase 4 (post-marketing) studies? - (answer)Ongoing safety monitoring
through periodic safety updates and new studies for new indications, populations, or specific
safety issues.
What is a generic drug? - (answer)A drug not required to demonstrate safety/efficacy but must
have the same dose(s), form, route of administration, chemistry, and manufacturer, and show
similar bioavailability.
AND ANSWERS 2026 LATEST UPDATED | 100% GRADED CORRECT |
100% GUARANTEED TO PASS | GET A+
What are the pre-clinical candidate development criteria for new drugs? - (answer)Proof of
efficacy (in vitro potency, in vitro selectivity, efficacy in animals, target engagement, disease
markers) and proof of safety (ancillary pharmacology, metabolism data, off-target in vitro
activities, dose limiting toxicity studies).
What occurs during the Discovery Process: Preclinical Testing? - (answer)Initial
pharmacokinetic tests (absorption, distribution, metabolism, excretion, and toxicity), alteration of
molecule structure for safety/effectiveness, animal testing for safety confirmation, patent pursuit,
and filing of Investigational New Drug (IND) application.
When should the Investigational New Drug (IND) application be filed? - (answer)Before clinical
testing.
When should the New Drug Application (NDA) be submitted? - (answer)At the end of Phase 3,
depending on results.
, What are the key features of Phase 1 clinical trials? - (answer)Focus on safety with 20-80 healthy
volunteers, assessment of most frequent adverse effects, and metabolism & excretion.
What are the key features of Phase 2 clinical trials? - (answer)Focus on effectiveness with
hundreds of patients with disease, may include dose determination, continued safety evaluation,
and discussions on Phase 3 methodologies.
What are the key features of Phase 3 clinical trials? - (answer)Focus on safety and effectiveness
with thousands of patients, may address sub-populations and relevant comparators, and involves
submission of NDA or Biologics License Application (BLA).
What are the US criteria for drug approval? - (answer)Safety, efficacy, and good manufacturing
practices.
What is the purpose of Phase 4 (post-marketing) studies? - (answer)Ongoing safety monitoring
through periodic safety updates and new studies for new indications, populations, or specific
safety issues.
What is a generic drug? - (answer)A drug not required to demonstrate safety/efficacy but must
have the same dose(s), form, route of administration, chemistry, and manufacturer, and show
similar bioavailability.
